EPFL Company Profile

18:32 EDT 21st March 2018 | BioPortfolio

EPFL is one of the two Ecoles Polytechniques fédérales in Switzerland. Like its sister institution, ETHZ, it has three missions: education, research and technology transfer at the highest international level. Associated with several specialised research institutes, the two EPFs form the EPF domain, which is directly dependent on the Federal Department of Home Affairs. EPFL, in its idyllic location on the shores of Lake Geneva, brings together a campus of more than 10,000 people. By its novel structure, the school stimulates collaboration between students, professors, researchers and entrepreneurs. These daily interactions give rise to new and groundbreaking work in science, technology and architecture.


CE 3 316 (Centre Est), Station 1


Phone: 021 693 11 11

News Articles [32 Associated News Articles listed on BioPortfolio]

Novel Omics tool begins new era for biology and personalized medicine

(Ecole Polytechnique Fédérale de Lausanne) Researchers from EPFL have developed a novel series of systems genetics tools to identify new links between genes and phenotypes. The work, a hallmark of E...

GRT Group and EPFL create the world's first formic acid-based fuel cell

(Ecole Polytechnique Fédérale de Lausanne) Scientists at EPFL and GRT Group have built the world's first integrated power supply unit that can produce electricity from formic acid, using a fuel cell...

Calculating the CO2 emissions of biofuels is not enough

(Ecole Polytechnique Fédérale de Lausanne) A new EU regulation aims to shrink the environmental footprint of biofuels starting in 2021. But an EPFL scientist thinks we should go one step further and...

Light and copper catalysis improves amine synthesis

(Ecole Polytechnique Fédérale de Lausanne) EPFL chemists have developed a novel and efficient method to make amines, which are among the most important structural compounds in pharmaceuticals and or...

Boosting cancer therapy with cross-dressed immune cells

(Ecole Polytechnique Fédérale de Lausanne) Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Natu...

Removing heavy metals from water

(Ecole Polytechnique Fédérale de Lausanne) EPFL chemists have developed a new material that can remove heavy metals from water and make it drinkable in seconds. The study is published in ACS Central...

The immune cells that help tumors instead of destroying them

(Ecole Polytechnique Fédérale de Lausanne) EPFL scientists have discovered that neutrophils, a type of immune cell, can actually help lung tumors grow. The work is published in Cell Reports, and has...

Bile acids fire up fat burning

(Ecole Polytechnique Fédérale de Lausanne) EPFL scientists have discovered a novel role for bile acids: converting energy-storing white fat depots into energy-expending beige fat. The study is publi...

Drugs and Medications [0 Results]


PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Multi-scale modelling to evaluate building energy consumption at the neighbourhood scale.

A new methodology is proposed to couple a meteorological model with a building energy use model. The aim of such a coupling is to improve the boundary conditions of both models with no significant inc...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Enhancing Social Interaction With an AlterEgo Artificial Agent

The objective of AlterEgo is the creation of an interactive cognitive architecture, implementable in various artificial agents, allowing a continuous interaction with patients suffering fr...

LEAP a New Overground Body Weight Support Robot: Usability Trial

People with central nervous system disorders such as spinal cord injury, stroke, cerebral palsy, Parkinson's disease, multiple sclerosis, etc… often have impaired lower extremity functio...

Companies [9 Associated Companies listed on BioPortfolio]


EPFL is one of the two Ecoles Polytechniques fédérales in Switzerland. Like its sister institution, ETHZ, it has three missions: education, research and technology transfer at the highest internatio...


Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abi...

Suriasis SA

Suriasis will provide advanced chemical surface treatments to companies in the dental and orthopedic implant industry who need to better control the tissue-implant interface. Suriasis means “Healing...

Ayanda Biosystems SA

Ayanda Biosystems S.A. ("Ayanda") is a technology development company of innovative tools for medical diagnostics and drug discovery applications. Founded in June 2001, Ayanda (a South African name si...

Venture Valuation Inc.

Venture Valuation was founded in spring 1999 based on research work by the founder and CEO, Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne...

More Information about "EPFL" on BioPortfolio

We have published hundreds of EPFL news stories on BioPortfolio along with dozens of EPFL Clinical Trials and PubMed Articles about EPFL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EPFL Companies in our database. You can also find out about relevant EPFL Drugs and Medications on this site too.

Quick Search


Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record